Chrome Extension
WeChat Mini Program
Use on ChatGLM

Cancer Risk in IBD Patients Treated with JAK Inhibitors: Reassuring Evidence from Trials and Real-World Data

Pierluigi Puca,Angelo Del Gaudio, Jacopo Iaccarino, Valentina Blasi, Gaetano Coppola, Lucrezia Laterza, Loris Riccardo Lopetuso,Stefania Colantuono,Antonio Gasbarrini,Franco Scaldaferri,Alfredo Papa

Cancers(2025)

Cited 0|Views0
Key words
JAK inhibitors,malignancies,cancer,tofacitinib,upadacitinib,filgotinib,inflammatory bowel disease
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined